Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1140867

registered interest
date	22/07/2019
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Synthetic Cannabinoids: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, if he will make an assessment of the effectiveness of the penalties incurred for (a) possession and (b) supply and production of synthetic cannabinoids.
tabling member constituency	Mansfield
tabling member printed	Ben Bradley
uin	280381
answer	answer is ministerial correction date of answer 24/07/2019 answer text <p>Synthetic cannabinoids are controlled as Class B drugs under the Misuse of Drugs Act 1971. There is a maximum penalty of five years’ imprisonment, an unlimited fine, or both for possession of a Class B drug and 14 years’ imprisonment, an unlimited fine, or both, for the supply and production of a Class B drug.</p><p>There was a total of 281 convictions for the principal offence of possession of synthetic cannabinoids in 2018, up from 71 convictions in 2017 and no convictions in 2016. For the principal offences of either supply, possession with intent to supply or production of synthetic cannabinoids there were 18 convictions in 2018, up from 4 convictions in 2017 and 4 convictions in 2016.</p><p>The Government has commissioned the Advisory Council on the Misuse of Drugs (ACMD) to provide an updated harms assessment on their previous reports on synthetic cannabinoids. The commission also seeks recommendations on whether the current classification under the Misuse of Drugs Act 1971 of synthetic cannabinoids is appropriate. The advice is due in summer 2020. The full commission has been published online on the gov.uk website. <br>The Government will await the ACMD’s further advice and recommendations</p> answering member constituency Ruislip, Northwood and Pinner answering member printed Mr Nick Hurd question first answered 24/07/2019 16:00:51 answering member 1561 label Biography information for Mr Nick Hurd
tabling member	4663 label Biography information for Ben Bradley

1140868

registered interest
date	22/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prisoners: Synthetic Cannabinoids
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what programmes there are in prisons to provide support for prisoners with synthetic cannabis drug dependency.
tabling member constituency	Mansfield
tabling member printed	Ben Bradley
uin	280382
answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>In prison, patients presenting with problematic psychoactive substance use are assessed in the same way as other drug users and offered an appropriate range of psychosocial interventions.</p><p>In April 2018, NHS England and NHS Improvement published its updated service specification on ‘Integrated Substance Misuse Treatment Service in Prisons in England’. This is fully aligned to ‘Drug Misuse and Dependence: UK Guidelines on Clinical Management’, which sets out how clinicians should treat people with drug misuse and drug dependence problems.</p><p>The service specification describes a fully recovery orientated, integrated prison substance misuse treatment service, which covers traditional drugs of abuse, psychoactive substances (including synthetic cannabis), illicit abuse of prescribed and over the counter drugs and alcohol.</p><p>This improved substance misuse service offer is now being commissioned across all prisons and secures integration with mental health services so that growing numbers of people in prisons can access services to support their recovery and wellbeing.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 25/07/2019 16:15:47 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4663 label Biography information for Ben Bradley

1132879

registered interest
date	18/06/2019
answering body	Cabinet Office
answering dept id	53
answering dept short name	Cabinet Office
answering dept sort name	Cabinet Office
hansard heading	Public Bodies
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Minister for the Cabinet Office, what the annual cost to the public purse of the 406 agencies and other public bodies listed on the gov.uk website is.
tabling member constituency	Mansfield
tabling member printed	Ben Bradley
uin	266186
answer	answer is ministerial correction date of answer 26/06/2019 answer text <p>The Public Bodies 2018/19 report, published on 22 March 2019, sets out the gross resource expenditure of<br>the 301 arm’s length bodies which include all executive agencies and non-departmental public bodies as well<br>as non-ministerial departments, the latter of which are not included in the 406 bodies listed on gov.uk. As of<br>31 March 2018, the gross resource expenditure was £203.8 billion. Further information on how this cost is<br>broken down per organisation across services provided, running costs of the organisation and other costs<br>can be obtained from the organisations directly</p><p>The annual cost to the public purse of the other public bodies listed on the gov.uk website is not held<br>centrally.</p> answering member constituency Torbay answering member printed Kevin Foster question first answered 26/06/2019 15:46:05 answering member 4451 label Biography information for Kevin Foster
tabling member	4663 label Biography information for Ben Bradley

1123105

registered interest
date	25/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Autism: Females
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent steps his Department has taken to improve the diagnosis of autism in women.
tabling member constituency	Mansfield
tabling member printed	Ben Bradley
uin	247783
answer	answer is ministerial correction date of answer 02/05/2019 answer text <p>We are committed to ensuring all adults and children receive a timely autism diagnosis in line with National Institute for Health and Care Excellence guidance.</p><p> </p><p>The NHS Long Term Plan was published on 7 January 2019. The Plan commits to improving autism diagnostic pathways in England and ensuring autistic people have access to high-quality care and support in the community. Over the next three years, autism diagnosis will be included alongside work with children and young people’s mental health services to test and implement the most effective ways to reduce waiting times for specialist services. This will be a step towards achieving timely diagnostic assessments in line with best practice guidelines.</p><p> </p><p>The Department is determined to drive up performance on autism diagnosis nationally. To support this NHS Digital began formally collecting autism diagnosis waiting time data, including information on gender, from mental health provider trusts for the first time through the Mental Health Services Data set in April 2018.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 02/05/2019 13:44:47 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4663 label Biography information for Ben Bradley